BioSpace News Archive

The grant is part of the Bill & Melinda Gates Family Planning program, whose goal is to provide access to high-quality contraceptive information, services and supplies to women in low- and middle-income countries.

Company Offers Novel Ebola Vaccine for Public Health use...Gratis

Contribution of $2.75 Million to Scale-up, Meet Demand, and Create Highly-Skilled Jobs

New research among INFORMS members is saving hospitals big bucks.

Noted Behavioral Health Leader Brings Deep Field Expertise to Company, Ability to Accelerate Client Growth and Behavioral Health Integration

Citius Pharmaceuticals, Inc., a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, reported the Company’s decision to develop Mino-Wrap as a drug through the Investigational New Drug process.

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the Company will release its second quarter financial results on Tuesday, August 6, 2019, after the close of US markets.

Audentes Therapeutics, Inc. (Nasdaq: BOLD), a leading AAV-based genetic medicines company focused on developing and commercializing innovative products for serious rare neuromuscular diseases, will host a conference call and webcast to report its second quarter 2019 financial results and provide a corporate update on Tuesday, August 6, 2019.

Certara®, the global model-informed drug development and decision support leader, today announced the launch of version 19.6 of D360, its scientific informatics platform for drug discovery and development

The not-for-profit community medical center is partnering with Glytec to facilitate standardization of best practices in diabetes therapy management.